Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies

N/A

http://ijhpm.com Int J Health Policy Manag 2017, 6(9), 509–518 doi 10.15171/ijhpm.2017.11 Original Article Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies Pascale Lehoux1,2,3*, Fiona A. Miller4, Geneviève Daudelin2, Jean-Louis Denis5,6 Abstract…

related reading

• The Bright Elusive Butterfly of Value in Health Technology Development Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”ijhpm.com
• Health Technology is Weirdblog.spec.tech
• Tech vs Biotech - Celine Haliouacelinehh.com
• Early-Stage Biotech Value Creation: The Roles of Equity and Partnershipsleadershipandbiotechnology.blogspot.com
• .:: Phrack Magazine ::.phrack.org
• Biotech Startups: Move Slow and Fix Things - Stanford Biotechnology Groupstanfordbiotechgroup.com
• Eight lessons from the first climate tech boom and bust - Bessemer Venture Partnersbvp.com
• Hey Tech, It's Time To Build. In Healthcare. | Andreessen Horowitza16z.com
• Research – Deepak Hegdedhegde.com
• A primer for academic entrepreneurs on academic-industrial partnerships | Nature Communicationsnature.com
• A primer for academic entrepreneurs on academic-industrial partnerships | Nature Communicationsnature.com
• Curious cases of financial engineering in biotechowlposting.com